MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/fpc.0b013e32832c347d

Медицинская библиотека · Pharmacogenetics and genomics · 2009

High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients.

Kazeem Gbenga R, Cox Charles, Aponte Jennifer, Messenheimer John, Brazell Celia, Nelsen Andrew C, Nelson Matthew R, Foot Elizabeth

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Severe cutaneous adverse reactions (SCARs) are associated with over 200 medicines including lamotrigine, an antiepileptic drug. Previous studies have suggested the involvement of immune mechanisms in the development of drug-induced SCARs.

METHODS

High-resolution HLA genotyping was performed for 65 patients of European ancestry treated with lamotrigine (22 cases with lamotrigine-induced SCARs and 43 controls on lamotrigine without SCAR-related symptoms). Association of HLA genetic variants with SCARs in these patients were evaluated by contrasting allele frequencies between the cases and the controls for each of 112 HLA four-digit alleles.

RESULTS

Five alleles were observed with higher frequencies in the cases compared with the treated controls with exact P values less than 0.05. These include B*5801 (P = 0.037), previously reported to be associated with allopurinol-induced SCARs. Marginal association evidence was also observed for alleles Cw*0718 and DQB1*0609, both of which were strongly correlated with B*5801. Other alleles identified were A*6801 (P = 0.012) and DRB1*1301 (P = 0.045). In contrast to the study of carbamazepine-induced Stevens-Johnson syndrome in Han Chinese patients, none of the cases carried B*1502. Accounting for the large number of hypothesis tests conducted, none of the associations identified were statistically significant.

CONCLUSION

No single major HLA-related genetic risk factor was identified for lamotrigine-induced SCARs in patients of European origin. Only suggestive evidence was obtained for B*5801, A*6801, Cw*0718, DQB1*0609, and DRB1*1301. Confirmation of these results in a larger, independent sample is needed to determine whether any of the HLA alleles identified are truly associated with the development of lamotrigine-induced SCARs.

Для цитирования: Kazeem Gbenga R, Cox Charles, Aponte Jennifer, Messenheimer John, Brazell Celia, Nelsen Andrew C, Nelson Matthew R, Foot Elizabeth. High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients.. Pharmacogenetics and genomics. 2009. DOI: 10.1097/fpc.0b013e32832c347d.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.